Global Actinic (Solar) Keratosis Treatment Market Research Report 2012-2023

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

1.1.2 Specifications

1.2 Market Segment

1.2.1 by Type

1.2.1.1 854-A

1.2.1.2 ACT-01

1.2.1.3 AD-17137

1.2.1.4 Celecoxib

1.2.1.5 DFD-08

1.2.1.6 GDC-695

1.2.1.7 Others

1.2.2 by Application

1.2.2.1 Hospital

1.2.2.2 Clinic

1.2.2.3 Others

1.2.3 by Regions

2 Industry Chain

2.1 Industry Chain Structure

2.2 Upstream

2.3 Market

2.3.1 SWOT

2.3.2 Dynamics

3 Environmental Analysis

3.1 Policy

3.2 Economic

3.3 Technology

3.4 Market Entry

4 Market Segmentation by Type

4.1 Market Size

4.1.1 854-A Market, 2012-2017

4.1.2 ACT-01 Market, 2012-2017

4.1.3 AD-17137 Market, 2012-2017

4.1.4 Celecoxib Market, 2012-2017

4.1.5 DFD-08 Market, 2012-2017

4.1.6 GDC-695 Market, 2012-2017

4.1.7 Others Market, 2012-2017

4.2 Market Forecast

4.2.1 854-A Market Forecast, 2018-2023

4.2.2 ACT-01 Market Forecast, 2018-2023

4.2.3 AD-17137 Market Forecast, 2018-2023

4.2.4 Celecoxib Market Forecast, 2018-2023

4.2.5 DFD-08 Market Forecast, 2018-2023

4.2.6 GDC-695 Market Forecast, 2018-2023

4.2.7 Others Market Forecast, 2018-2023

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Hospital Market, 2012-2017

5.1.2 Clinic Market, 2012-2017

5.1.3 Others Market, 2012-2017

5.2 Market Forecast

5.2.1 Hospital Market Forecast, 2018-2023

5.2.2 Clinic Market Forecast, 2018-2023

5.2.3 Others Market Forecast, 2018-2023

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2012-2017

6.1.1.2 Asia-Pacific Market by Type

6.1.1.3 Asia-Pacific Market by Application

6.1.2 North America

6.1.2.1 North America Market, 2012-2017

6.1.2.2 North America Market by Type

6.1.2.3 North America Market by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2012-2017

6.1.3.2 Europe Market by Type

6.1.3.3 Europe Market by Application

6.1.4 South America

6.1.4.1 South America Market, 2012-2017

6.1.4.2 South America Market by Type

6.1.4.3 South America Market by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2012-2017

6.1.5.2 Middle East & Africa Market by Type

6.1.5.3 Middle East & Africa Market by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2018-2023

6.2.2 North America Market Forecast, 2018-2023

6.2.3 Europe Market Forecast, 2018-2023

6.2.4 South America Market Forecast, 2018-2023

6.2.5 Middle East & Africa Market Forecast, 2018-2023

7 Market Competitive

7.1 Global Market by Vendors

7.2 Market Concentration

7.3 Price & Factors

7.4 Marketing Channel

8 Major Vendors

8.1 3M Drug Delivery Systems

8.1.2 Profile

8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.2 Athenex Inc

8.2.1 Profile

8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.3 CritiTech Inc

8.3.1 Profile

8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.4 Foamix Pharmaceuticals Ltd

8.4.1 Profile

8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.5 G&E Herbal Biotechnology Co Ltd

8.5.1 Profile

8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.6 Galderma SA

8.6.1 Profile

8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.7 Laboratories Ojer Pharma SL

8.7.1 Profile

8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.8 LEO Pharma A/S

8.8.1 Profile

8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.9 Novartis AG

8.9.1 Profile

8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.10 Oncology Research International Ltd

8.10.1 Profile

8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.11 Promius Pharma LLC

8.12 Valeant Pharmaceuticals International Inc

8.13 Vectura Group Plc

9 Conclusion

Table Products Segment of Actinic (Solar) Keratosis Treatment

Table 854-A Overview

Table ACT-01 Overview

Table AD-17137 Overview

Table Celecoxib Overview

Table DFD-08 Overview

Table GDC-695 Overview

Table Others Overview

Table Global Actinic (Solar) Keratosis Treatment Market by Type, 2011-2022 (USD Million)

Table Application Segment of Actinic (Solar) Keratosis Treatment

Table Hospital Overview

Table Clinic Overview

Table Others Overview

Table Global Actinic (Solar) Keratosis Treatment Market by Application, 2011-2022 (USD Million)

Table Global Actinic (Solar) Keratosis Treatment Market by Region, 2011-2022 (USD Million)

Table Cost of Actinic (Solar) Keratosis Treatment

Table Market Dynamics

Table Policy of Actinic (Solar) Keratosis Treatment

Table GDP of Major Countries

Table 854-A CAGR by Revenue and Volume, 2012-2017

Table ACT-01 CAGR by Revenue and Volume, 2012-2017

Table AD-17137 CAGR by Revenue and Volume, 2012-2017

Table Celecoxib CAGR by Revenue and Volume, 2012-2017

Table DFD-08 CAGR by Revenue and Volume, 2012-2017

Table GDC-695 CAGR by Revenue and Volume, 2012-2017

Table Others CAGR by Revenue and Volume, 2012-2017

Table 854-A CAGR by Revenue and Volume, 2012-2022

Table ACT-01 CAGR by Revenue and Volume, 2012-2022

Table AD-17137 CAGR by Revenue and Volume, 2012-2022

Table Celecoxib CAGR by Revenue and Volume, 2012-2022

Table DFD-08 CAGR by Revenue and Volume, 2012-2022

Table GDC-695 CAGR by Revenue and Volume, 2012-2022

Table Others CAGR by Revenue and Volume, 2012-2022

Table Hospital CAGR by Revenue and Volume, 2012-2017

Table Clinic CAGR by Revenue and Volume, 2012-2017

Table Others CAGR by Revenue and Volume, 2012-2017